Appaloosa Management Sold Entire Stake In American Airlines Group; ASML Holding; Delta Air Lines; Deutsche Bank; Goodyear Tire & Rubber Company; IQVIA Holdings; Mohawk Industries; Owens Corning; Taiwan Semiconductor Manufacturing Company; United Airlines Holdings.
IQVIA Holdings Inc IQV
$169.12
▼ -0.91%
($-1.56)
Index member:
S&P 500
Open
$170.07
Prev Close
$170.68
Day Range
$168.68 – $173.35
52W Range
$134.65 – $247.05
Market Cap
$29.22B
P/E (TTM)
20.57
Beta
1.20
EPS (TTM)
$8.07
📋 Company Profile
| Industry | Life Sciences Tools & Services |
| Sector | Health Care |
| Country | US |
| Exchange | NEW YORK STOCK EXCHANGE, INC. |
| Currency | USD |
| IPO Date | 2013-05-09 |
| Shares Out. | 167,870,000 |
| Website | ir.iqvia.com/ ↗ |
| Phone | 18009279800 |
IQVIA Holdings Inc is a publicly traded company under the ticker symbol IQV on the NEW YORK STOCK EXCHANGE, INC., operating in the Life Sciences Tools & Services industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
31 analysts (2026-05-01)
📰 Latest News for IQV
Will IQVIA's (IQV) AI‑Driven Biosimilar Partnership with Kexing Reshape Its Long‑Term Narrative?
IQVIA’s Q1 Earnings Call: Our Top 5 Analyst Questions
The Broyhill Q1 2026 Portfolio Strategy And Positioning
Veeva Systems Expands AI and Vault CRM Momentum: Time to Buy or Hold?
IQVIA and Kexing Biopharm Expand Strategic Collaboration to Accelerate Global Biosimilar Development using AI-Enabled Capabilities
IQVIA Holdings Inc. (IQV) Presents at Bank of America Global Healthcare Conference 2026 Transcript
IQVIA Advances Strategic Collaboration With Kexing Biopharm To Support Global, Multi-Product Biosimilar Development And Commercialization Program